| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.962 | 0.001 | 0.962 | HIV-1 reverse transcriptase inhibitor | 0.931 0.001 CHEMBL3526537 0.934 0.001 CHEMBL1309 0.925 0.001 CHEMBL4525789 0.874 0.002 CHEMBL3526538 | ||
| 0.855 | 0.003 | 0.855 | DNA directed RNA polymerase inhibitor | 0.766 0.003 CHEMBL3526537 0.801 0.003 CHEMBL1309 0.765 0.003 CHEMBL4525789 0.603 0.004 CHEMBL3526538 | ||
| 0.582 | 0.006 | 0.593 | RNA-directed DNA polymerase inhibitor | 0.593 0.006 CHEMBL3526537 0.554 0.008 CHEMBL1309 0.559 0.007 CHEMBL4525789 0.45 0.014 CHEMBL3526538 | CHEMBL3526537 | |
| 0.44 | 0.017 | 0.44 | Anticonvulsant | 0.161 0.117 CHEMBL3526537 0.203 0.08 CHEMBL1309 0.351 0.029 CHEMBL3526538 | ||
| 0.307 | 0.003 | 0.307 | Progesterone antagonist | 0.225 0.004 CHEMBL3526537 0.188 0.005 CHEMBL1309 0.125 0.007 CHEMBL4525789 0.275 0.004 CHEMBL3526538 | ||
| 0.374 | 0.096 | 0.374 | Analgesic | 0.282 0.156 CHEMBL3526537 0.267 0.168 CHEMBL1309 0.296 0.145 CHEMBL3526538 | ||
| 0.243 | 0.017 | 0.343 | Glutamate receptor antagonist | 0.183 0.032 CHEMBL3526537 0.186 0.03 CHEMBL1309 0.175 0.036 CHEMBL4525789 0.343 0.007 CHEMBL3526538 | CHEMBL3526538 | |
| 0.317 | 0.105 | 0.317 | Antiobesity | 0.222 0.185 CHEMBL3526537 0.261 0.147 CHEMBL1309 0.282 0.129 CHEMBL3526538 | ||
| 0.207 | 0.013 | 0.295 | Androgen antagonist | 0.235 0.01 CHEMBL3526537 0.239 0.01 CHEMBL1309 0.174 0.017 CHEMBL4525789 0.295 0.007 CHEMBL3526538 | CHEMBL3526538 | |
| 0.188 | 0.004 | 0.188 | Mineralocorticoid receptor antagonist | 0.135 0.005 CHEMBL3526537 0.119 0.006 CHEMBL1309 0.116 0.006 CHEMBL4525789 0.171 0.005 CHEMBL3526538 | ||
| 0.18 | 0.007 | 0.222 | NMDA 2B receptor antagonist | 0.168 0.008 CHEMBL3526537 0.183 0.007 CHEMBL1309 0.143 0.009 CHEMBL4525789 0.222 0.005 CHEMBL3526538 | CHEMBL3526538 | |
| 0.205 | 0.033 | 0.231 | ATPase inhibitor | 0.169 0.073 CHEMBL3526537 0.218 0.025 CHEMBL1309 0.143 0.114 CHEMBL4525789 0.231 0.019 CHEMBL3526538 | CHEMBL3526538 | |
| 0.182 | 0.011 | 0.182 | Glutamate (mGluR) agonist | 0.122 0.018 CHEMBL3526537 0.118 0.019 CHEMBL1309 0.092 0.026 CHEMBL4525789 | ||
| 0.239 | 0.073 | 0.326 | Hypolipemic | 0.225 0.08 CHEMBL3526537 0.239 0.072 CHEMBL1309 0.202 0.092 CHEMBL4525789 0.326 0.041 CHEMBL3526538 | CHEMBL3526538 | |
| 0.121 | 0.026 | 0.121 | Glutamate receptor agonist | 0.068 0.065 CHEMBL3526537 | ||
| 0.091 | 0.006 | 0.091 | Factor XIa inhibitor | 0.042 0.026 CHEMBL3526537 0.044 0.025 CHEMBL1309 | ||
| 0.074 | 0.004 | 0.074 | Progesterone agonist | 0.04 0.005 CHEMBL3526537 0.037 0.005 CHEMBL1309 0.035 0.006 CHEMBL4525789 0.071 0.004 CHEMBL3526538 | ||
| 0.075 | 0.014 | 0.075 | Glutamate (mGluR group I) agonist | |||
| 0.152 | 0.092 | 0.199 | Antipruritic | 0.199 0.049 CHEMBL1309 | CHEMBL1309 | |
| 0.187 | 0.132 | 0.187 | Cardiotonic | 0.18 0.14 CHEMBL1309 | ||
| 0.061 | 0.016 | 0.061 | Carnitine palmitoyltransferase 1B inhibitor | 0.046 0.037 CHEMBL3526537 0.049 0.031 CHEMBL1309 0.05 0.03 CHEMBL3526538 | ||
| 0.059 | 0.018 | 0.059 | Glutamate (mGluR5) agonist | |||
| 0.055 | 0.015 | 0.055 | Parathyroid hormone antagonist | 0.048 0.025 CHEMBL3526537 0.045 0.031 CHEMBL1309 0.046 0.03 CHEMBL4525789 | ||
| 0.219 | 0.185 | 0.219 | GABA C receptor rho-3 antagonist | |||
| 0.046 | 0.012 | 0.046 | Factor XI inhibitor | |||
| 0.092 | 0.067 | 0.092 | Phosphodiesterase 7B inhibitor | |||
| 0.043 | 0.018 | 0.092 | Glucocorticoid antagonist | 0.04 0.019 CHEMBL3526537 0.029 0.025 CHEMBL1309 0.092 0.005 CHEMBL3526538 | CHEMBL3526538 | |
| 0.069 | 0.045 | 0.117 | Potassium channel large-conductance Ca-activated activator | 0.065 0.051 CHEMBL3526537 0.103 0.023 CHEMBL1309 0.117 0.017 CHEMBL3526538 | CHEMBL3526538 | |
| 0.058 | 0.036 | 0.058 | Kallikrein 1 inhibitor | 0.051 0.05 CHEMBL3526537 | ||
| 0.027 | 0.011 | 0.027 | Elastase 2A inhibitor | |||
| 0.027 | 0.011 | 0.027 | Elastase 2 inhibitor | |||
| 0.151 | 0.137 | 0.151 | Neurotrophic factor enhancer | |||
| 0.069 | 0.055 | 0.069 | Phospholipase D inhibitor | |||
| 0.065 | 0.056 | 0.065 | Prostaglandin-E synthase inhibitor | |||
| 0.054 | 0.047 | 0.061 | Pregnane X receptor antagonist | 0.061 0.028 CHEMBL3526537 0.056 0.042 CHEMBL1309 | CHEMBL3526537 | |
| 0.076 | 0.071 | 0.076 | NMDA receptor antagonist | |||
| 0.063 | 0.058 | 0.081 | NMDA 2 receptor antagonist | 0.066 0.055 CHEMBL1309 0.081 0.043 CHEMBL3526538 | CHEMBL3526538 | |
| 0.044 | 0.039 | 0.044 | Aldosterone antagonist | |||
| 0.027 | 0.023 | 0.027 | Carnitine palmitoyltransferase 1A inhibitor | |||
| 0.032 | 0.03 | 0.032 | p53 inhibitor | |||
| 0.04 | 0.038 | 0.04 | Alpha 1L adrenoreceptor agonist | |||
| 0.047 | 0.067 | 0.056 | NMDA 2C receptor antagonist | 0.056 0.051 CHEMBL1309 | CHEMBL1309 | |
| 0.045 | 0.067 | 0.058 | Androgen agonist | 0.058 0.044 CHEMBL3526537 | CHEMBL3526537 | |
| 0.032 | 0.058 | 0.094 | Glutamate (mGluR5) antagonist | 0.094 0.011 CHEMBL3526538 | CHEMBL3526538 | |
| 0.019 | 0.063 | 0.03 | ATP citrate lysase inhibitor | 0.03 0.026 CHEMBL3526537 | CHEMBL3526537 | |
| 0.112 | 0.169 | 0.141 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.141 0.09 CHEMBL3526537 | CHEMBL3526537 | |
| 0.02 | 0.079 | 0.043 | Dopamine D2 agonist | 0.043 0.032 CHEMBL1309 0.039 0.035 CHEMBL3526538 | CHEMBL1309 | |
| 0.041 | 0.122 | 0.089 | Glutamate (mGluR group I) antagonist | 0.089 0.031 CHEMBL3526538 | CHEMBL3526538 | |
| 0.054 | 0.138 | 0.095 | Estrogen receptor alpha antagonist | 0.088 0.037 CHEMBL3526537 0.07 0.068 CHEMBL1309 0.095 0.03 CHEMBL3526538 | CHEMBL3526538 | |
| 0.043 | 0.128 | 0.091 | Glutamate (mGluR) antagonist | 0.091 0.041 CHEMBL3526538 | CHEMBL3526538 | |
| 0.106 | 0.21 | 0.228 | Lipocortins synthesis antagonist | 0.228 0.041 CHEMBL3526538 | CHEMBL3526538 | |
| 0.161 | 0.281 | 0.264 | Antibacterial | 0.224 0.203 CHEMBL3526537 0.263 0.165 CHEMBL1309 0.264 0.164 CHEMBL4525789 | CHEMBL4525789 | |
| 0.176 | 0.312 | 0.297 | Cyclophilin D inhibitor | 0.297 0.166 CHEMBL3526538 | CHEMBL3526538 | |
| 0.05 | 0.206 | 0.124 | Estrogen receptor beta antagonist | 0.121 0.031 CHEMBL3526537 0.101 0.062 CHEMBL1309 0.09 0.084 CHEMBL4525789 0.124 0.028 CHEMBL3526538 | CHEMBL3526538 | |
| 0.165 | 0.347 | 0.309 | Calcium channel L-type activator | 0.309 0.15 CHEMBL3526537 | CHEMBL3526537 | |
| 0.048 | 0.303 | 0.138 | Estrogen antagonist | 0.123 0.05 CHEMBL3526537 0.102 0.094 CHEMBL1309 0.138 0.03 CHEMBL3526538 | CHEMBL3526538 | |
| 0.016 | 0.483 | 0.084 | Bronchodilator | 0.084 0.081 CHEMBL1309 0.084 0.081 CHEMBL4525789 | CHEMBL4525789 | |
| 0.042 | 0.611 | 0.232 | Toll-Like receptor 7 agonist | 0.232 0.164 CHEMBL1309 | CHEMBL1309 | |
| 0.038 | 0.626 | 0.222 | Toll-Like receptor agonist | 0.222 0.177 CHEMBL1309 | CHEMBL1309 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |